Quintrio
Home

SERVICES-HEALTH SERVICES

EUDA Health Holdings Limited Class A Ordinary Shares

EUDA

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

Last trade $15.00
Day change -$0.325 (-2.12%)
Day range $14.56 – $15.85
Volume 90,794
Market cap $46M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$45.9M
Price / earnings
—
Price / book
-7.71×
Price / sales
10.51×
EV / sales
11.1×
EV / EBITDA
-13.56×

Profitability

Earnings per share
-$3.80
Return on assets
-44.66%
Return on equity
191.12%
Dividend yield
0%

Liquidity and leverage

Debt / equity
-0.57×
Current ratio
0.79×
Quick ratio
0.79×
Cash ratio
0.03×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
—

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for EUDA, quarterly periods
Line itemQ1 FY2023 Mar 31, 2023Q4 FY2022 Dec 31, 2022
Revenue$1.7M—
Cost of revenue$1.3M$0
Gross profit$403.6K—
Selling, general and administrative$2.38M—
Research and development$0—
Total operating expenses$2.38M$1.23M
Operating income-$1.98M-$1.23M
Interest expense-$11.38K—
Income before taxes-$2.41M-$1.02M
Income taxes$985—
Net income-$2.41M-$1.02M
Net income attributable to common shareholders-$2.41M-$8.82M
EBITDA-$1.97M-$1.23M
Basic earnings per share-$2.40-$56.60
Diluted earnings per share-$2.40-$56.60

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

EUDA Health Holdings Limited announced that its subsidiary Melana International Pte. Ltd. was recognized as a winner of the SME100 Awards 2026 Singapore. Melana, founded in 2000, manages 31 properties across Singapore with 5,675 residential and commercial units. The award recognizes the company's capabilities in property and strata management and adds to multiple accolades received by Melana in 2026.

GlobeNewswire Inc.

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings announced that its partner Shenzhen Inno Immune received government approval under the 2025 Shenzhen Key Industry R&D Program to develop TCR-T cell therapies for solid tumors, with potential funding of approximately $434,688. EUDA holds distribution rights for selected immunotherapies in Malaysia through this partnership.

GlobeNewswire Inc.

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Health Holdings Limited received a notice from Nasdaq on April 23, 2026, indicating it failed to maintain the required minimum market value of listed securities of $35 million. The company has 180 calendar days until October 20, 2026, to regain compliance by achieving a market value of $35 million or more for at least ten consecutive business days. Failure to comply could result in delisting from Nasdaq.

GlobeNewswire Inc.

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

EUDA Health Holdings announced a major expansion of its longevity and regenerative medicine strategy by launching a comprehensive stem cell therapy platform and establishing its first clinic in Shenzhen, China. The company is upgrading Shenzhen Inno's cGMP facility to incorporate iPSC technology from GO POSB and Japanese partners, while opening a new longevity clinic offering stem cell therapies, AI-guided life cycle management, and integrated Eastern and Western medicine.

GlobeNewswire Inc.

EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia

Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd (“CK Health”) today. This strategic move marks an expansion of EUDA's presence in Malaysia and underscores its commitment to revolutionizing the healthcare landscape in the region.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Mar 23, 20261-for-20reverse split